Wird geladen...
Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brain
Although the newer antiretroviral (ARV) drugs are highly active against the human immunodeficiency virus (HIV) in the body compartment, they often fail to effectively tackle the HIV reservoir in the brain because of inefficient penetration to the blood-brain barrier (BBB). In this study, we investig...
Gespeichert in:
Veröffentlicht in: | J Control Release |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
2020
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7749038/ https://ncbi.nlm.nih.gov/pubmed/33010335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.09.050 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|